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430Objectives: In children with aortic valve disease associated with annular hypoplasia or complex multilevel left
ventricular outflow tract obstruction, the Ross procedure, combined with a modified Konno-type aortoventricu-
loplasty, is advocated. We aim to examine the fate of the neoaortic apparatus and assess neoaortic valve function
after the modified Ross–Konno procedure.
Methods: Forty-three patients, with a median age of 6 years, underwent the modified Ross–Konno procedure
with a myectomy but without the use of a ventricular septal patch. Serial postoperative echocardiograms
(n ¼ 187) were analyzed, and regression models adjusted for repeated measures were used to model the longi-
tudinal growth of the neoaortic annulus and root.
Results: Therewere 2 operative deaths (5%) and 1 late mortality. At 8 years, survival was 93% and freedom from
autograft, homograft, and all-cause reoperation was 100%, 81%, and 72%, respectively. The median
postprocedure diameter and z score were 14 mm (7-21 mm) andþ1.3 (3.0 toþ6.1) for the neoaortic annulus
and 21 mm (9-30 mm) andþ1.6 (1.3 toþ4.1) for the neoaortic root, respectively. Serial echocardiograms showed
a progressive increase in annular (þ0.56mm/year,P<.001) and root (þ0.89mm/year,P<.001) diameters but little
change in annular (0.07/year,P¼ .08) and root (0.002/year,P¼ .96) z scores. Autograft regurgitation developed
in 9 patients; however, the degree and progression of regurgitation over time were not significant (P ¼ .22).
Conclusions: After the modified Ross–Konno procedure, the neoaortic annulus and root increased in size pro-
portionately to somatic growth. Autograft regurgitation, usually mild and stable, developed in few patients, and
none required autograft reoperation. Our findings support the use of the modified Ross–Konno as the procedure
of choice in children with aortic valve disease and complex left ventricular outflow tract obstruction. (J Thorac
Cardiovasc Surg 2013;145:430-7)Supplemental material is available online.
Aortic valve replacement (AVR)may be required in children
with significant irreparable aortic valve disease. In thosewith
a small aortic annulus or multilevel left ventricular outflow
tract obstruction (LVOTO), aortoventriculoplasty using the
Konno technique is highly effective in enlarging the left ven-
tricular outflow tract (LVOT) to enable postoperative relief of
gradient, especially in children.1 The classic Konno proce-
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The Journal of Thoracic and Cardiovascular Surgvalve insertion.1 Nonetheless, the use of prosthetic valves
in the pediatric population is associated with many draw-
backs, particularly in small children.2,3 The Ross procedure
counters many of the disadvantages of prosthetic valves. It
carries excellent hemodynamic characteristics and has
a low risk of endocarditis or thromboembolism, thus
allowing avoidance of anticoagulation requirement.4 The
potential for autograft growth offers another key advantage
of the Ross procedure in children requiring AVR.5,6 The
addition of Konno-type aortoventriculoplasty in conjunction
with the Ross procedure (Ross–Konno) has further allowed
the successful management of small children with aortic
valve disease associated with significant annular hypoplasia
and complex LVOTO.2
Nonetheless, the risk of neoaortic root dilatation leading
to neoaortic valve regurgitation or aneurysm formation ne-
cessitating surgical reintervention has emerged as a major
concern after the Ross procedure.7,8 Patients who undergo
the Ross–Konno procedure might be at a higher risk of
developing those autograft complications because of the
inherent disruption of the supporting aortic annular
structure at the time of aortoventriculoplasty.
There is little information available regarding the fate of
the neoaortic root and the function of the neoaortic valveery c February 2013
Abbreviations and Acronyms
AR ¼ aortic regurgitation
AVR ¼ aortic valve replacement
HR ¼ hazard ratio
LVOT ¼ left ventricular outflow tract
LVOTO ¼ left ventricular outflow tract obstruction
RV-PA ¼ right ventricle to pulmonary artery
VSD ¼ ventricular septal defect
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gested that preoperative aortic insufficiency and dilatation
of the aortic annulus with geometric mismatch between
the aortic and pulmonary annuli were risk factors for dispro-
portionate postoperative dilatation of the neoaortic appara-
tus after the Ross procedure.7,9-11 However, the findings of
those studies might not necessarily apply to the patient
population undergoing the Ross–Konno procedure who
predominantly had preoperative stenosis and a small
aortic annulus. The purpose of this study is to assess the
outcomes of patients after the modified Ross–Konno
procedure with particular emphasis on the fate of the
neoaortic valve and root.
MATERIALS AND METHODS
Inclusion Criteria
From 1994 to 2007, 43 consecutive patients underwent AVR plus annu-
lar enlargement using the modified Ross–Konno procedure at the King
Faisal Specialist Hospital and Research Center in Riyadh, Saudi Arabia.
Patients were identified using the hospital surgical database. Clinical, op-
erative, and outcome data were abstracted from their medical records. Ap-
proval of this study was obtained from the research ethics board at the King
Faisal Specialist Hospital and Research Center, and requirement for indi-
vidual consent was waived for this observational study.
Operative Details
Midline sternotomy was performed, and standard cardiopulmonary
bypass and myocardial protection techniques were used in all cases.
After the aorta was opened, the aortic valve, subvalvular area, and
LVOT were assessed for the possibility of valve repair. When replace-
ment was deemed necessary, the aortic valve cups were cut out and aortic
buttons containing the coronary artery ostia were excised. The pulmo-
nary autograft was then explanted, and the muscle rim underneath the
valve was thinned. With both the aortic and pulmonary valves removed,
the right ventricular outflow tract and LVOT became widely exposed,
which facilitated LVOT enlargement. Then the fibrous annulus of the
aortic valve was divided, and extensive septal myectomy below the
left/right commissure was performed. The muscle excision was often
made easy by palpating the septum between the fingers to make sure
that a ventricular septal defect (VSD) was not created while all levels
of LVOT obstruction were relieved. If needed, myectomy was extended
down into the left ventricular cavity. In 2 patients, resection of endocar-
dial fibroelastosis was performed. The pulmonary autograft was im-
planted as a full root with coronary transfer in all cases. Right
ventricle to pulmonary artery (RV-PA) continuity was established with
a homograft (n ¼ 42) or Contegra (Medtronic Inc, Minneapolis, Minn)
bovine jugular vein conduit (n ¼ 1). Mean homograft size was 20.5 
3.5 mm. Fresh homografts were used in 64% of cases, and cryopreservedThe Journal of Thoracic and Cahomografts were used in 36% of cases. Pulmonary homografts were
used in 67% of cases, and aortic homografts were used in 33% of cases.
Homografts were not generally matched for the blood group of the
patients.
Ten patients (23%) required additional concomitant cardiac surgery, in-
cluding mitral valve repair (n ¼ 4), aortic arch reconstruction (n ¼ 4), mi-
tral valve replacement (n¼ 1), pulmonary artery augmentation (n¼ 1), and
resection of ascending aortic aneurysm (n ¼ 1). Immediate postoperative
results were assessed in all patients in the operating room by means of
transesophageal echocardiography.
Follow-up
Patientswere evaluated clinically and bymeans of detailed echocardiog-
raphy on discharge, at 6 weeks after the operation, at 6 months, and yearly
thereafter. Late outcomes were determined from recent office visits at the
King Faisal Specialist Hospital and Research Center or from direct corre-
spondence with patients’ families. Follow-up was complete in 96% of the
patients.Median follow-updurationwas 5.3 years and rangedup to 14 years.
Echocardiography
Serial echocardiographic data were collected for the immediate postop-
erative study and for all future studies during the follow-up period. There
were a total of 187 studies performed in our patient cohort with a median
of 5 studies per subject (range, 2-11 studies). All measurements were per-
formed by an experienced cardiologist (B.M.F.), and the average of 3 inde-
pendent measurements was recorded. The diameters of the neoaortic valve
annulus and root were measured in the parasternal long-axis view. Grading
of neoaortic valve regurgitation was performed using the color Doppler–
derived ratio of the regurgitant jet width to the annular diameter in the para-
sternal long-axis view (aortic regurgitation [AR] ratio). According to the
recommendations of the American Society of Echocardiography, AR ratios
less than 0.25, 0.25 to 0.45, 0.46 to 0.64, and 0.65 or greater were consid-
ered to represent mild, mild-moderate, moderate-severe, and severe regur-
gitation, respectively.12
Statistical Analysis
Data are presented as means with standard deviation, medians with min-
imum and maximum values, and frequencies as appropriate. Long-term
survival and freedom from reoperations were estimated using the Kaplan–
Meiermethod.Cox regressionwas used to determine independent predictors
of late outcomes. Linear regression analysis, based on maximum likelihood
estimates, adjusted for repeatedmeasures with an autoregressive covariance
structure, was used to determine trends over time for serial echocardio-
graphic assessments of AR grade, neoaortic annulus diameter and z score,
and neoaortic root diameter and z score. These models consider every mea-
surement within each patient, as opposed to every patient, as an observation,
increasing our available sample size from 43 to 187 observations. The cor-
relation between observations is accounted for through the covariance struc-
ture. Each regression model included, in addition to specific patient
identifier, the covariates of interest, the time since themodified Ross–Konno
operation, and the interaction between the covariates of interest and the time
since surgery. Clinical relevance of identified covariates on likelihood of
selected outcomes was established by solving the regression equations for
multiple ‘‘typical’’ test patients. All statistical analyses were performed us-
ing SAS statistical software v9.1 (SAS Institute, Inc, Cary, NC).
RESULTS
Patient Characteristics
There were 29 male patients (67%). The median age at
the time of the modified Ross–Konno procedure was 6 years
(range, 15 days to 27 years). Underlying cardiac pathology
was congenital LVOTO in 39 patients (91%), endocarditisrdiovascular Surgery c Volume 145, Number 2 431
FIGURE 1. A, Trajectory of neoaortic annulus diameter growth over time
is nonlinear and increases over time. The fine solid lines represent individ-
ual patient trajectories, and the heavy solid line is a smoothing spline that
represents the best-fit average trend over time. Time zero was taken to be
the date of the modified Ross–Konno procedure. B, Trajectory of neoaortic
annulus z score over time. The fine solid lines represent individual patient
trajectories, and the heavy solid line is a smoothing spline that represents
the best-fit average trend over time. Time zero was taken to be the date
of the modified Ross–Konno procedure.
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erative in 1 patient (2%). Hemodynamic aortic valve dys-
function was primarily stenosis in 20 patients (47%),
mixed disease in 20 patients (47%), and primary regurgita-
tion in 3 patients (6%).
Clinical Outcomes
There were 2 operative deaths (5%) in infants who re-
quired concomitant mitral valve repair (n ¼ 1) and arch re-
construction plus mitral valve repair (n ¼ 1). In addition,
there was 1 late death in 1 patient who had arch reconstruc-
tion at the time of the modified Ross–Konno procedure as
a neonate and then required reoperation for ascending aor-
ta and recurrent arch obstruction followed by a second reop-
eration for homograft change, after which he died. Overall
1- and 10-year survival was 93%.
During follow-up, 12 patients had 13 cardiac reopera-
tions (28%). Those reoperations included homograft
change (n¼ 9), mitral valve repair (n¼ 2), repair of ascend-
ing aorta and recurrent arch obstruction (n¼ 1), and perma-
nent pacemaker insertion (n ¼ 1). Overall 8-year freedom
from homograft replacement was 81%. On multivariable
analysis, risk factors for homograft replacement were later
year of surgery (hazard ratio [HR], 3.3; P ¼ .03) and
additional cardiac surgery at the time of the modified
Ross–Konno procedure (HR, 5.1; P ¼ .02). Overall
10-year freedom from all-cause cardiac reoperation was
72%. On multivariable analysis, risk factors for cardiac re-
operation were again later year of surgery (HR, 5.9;
P ¼ .03) (Figure E1, A) and additional cardiac surgery at
the time of the modified Ross–Konno procedure (HR, 5.8;
P¼ .03) (Figure E1, B). None of the patients required auto-
graft reoperation during the follow-up.
Changes in Echocardiographic Parameters During
Follow-up
Median postprocedure neoaortic annulus diameter and z
scorewere 14mm (7-21mm) andþ1.3 (3.0 toþ6.1), respec-
tively, and median postprocedure root diameter and z score
were 21 mm (9-30) andþ1.6 (1.3 toþ4.1), respectively.
Longitudinal analysis of repeated echocardiographic
measures showed a progressive increase in neoaortic annu-
lus diameter with time (þ0.56 [0.06] mm/year, P< .001)
(Figure 1,A). Therewas no difference in the neoaortic annu-
lus diameter increase between patients who required cardiac
reoperation and thosewho did not (P¼ .56) or between those
who had preoperative stenosis and thosewho hadmixed dis-
ease or regurgitation (P¼ .76). On the other hand, there was
no significant increase in neoaortic annulus z scorewith time
(0.08 [0.04]/year, P ¼ .08) (Figure 1, B). Older patients
started with a lower neoaortic annulus z score immediately
after the modified Ross–Konno procedure but had a trend
for a more rapid increase in neoaortic annulus z score with
time (P ¼ .09) (Figure 2, A). Furthermore, patients who432 The Journal of Thoracic and Cardiovascular Surgunderwent additional cardiac surgery at the time of themod-
ified Ross–Konno procedure had a faster increase in neo-
aortic annulus z score with time (P ¼ .001) (Figure 2, B).
There was a progressive increase in neoaortic root
diameter with time (þ0.88 [0.09] mm/year, P < .001)
(Figure 3, A). There was no difference in the neoaortic
root diameter increase between patients who required
cardiac reoperation and those who did not (P ¼ .49) or be-
tween those who had preoperative stenosis and those who
had mixed disease or regurgitation (P ¼ .72). On the other
hand, there was no increase in neoaortic root z score with
time (0.002 [0.04]/year, P ¼ .96) (Figure 3, B). Older pa-
tients startedwith a lower neoaortic root z score immediately
after themodifiedRoss–Konno procedure but had a trend forery c February 2013
FIGURE 2. Trajectory of neoaortic annulus z score over time stratified by
(A) age group: Older patients start with a lower neoaortic annulus z score
immediately after the modified Ross–Konno procedure but have a trend for
a more rapid increase in neoaortic annulus z score with time; and (B) re-
quirement for additional surgery at the time of the modified Ross–Konno
procedure: Patients who underwent additional cardiac surgery at the time
of the modified Ross–Konno procedure had a faster increase in neoaortic
annulus z score with time.
FIGURE 3. A, Trajectory of neoaortic root diameter growth over time is
nonlinear and increases over time. The fine solid lines represent individual
patient trajectories, and the heavy solid line is a smoothing spline that rep-
resents the best-fit average trend over time. Time zero was taken to be the
date of the modified Ross–Konno procedure. B, Trajectory of neoaortic
root z score over time. The fine solid lines represent individual patient tra-
jectories, and the heavy solid line is a smoothing spline that represents the
best-fit average trend over time. Time zero was taken to be the date of the
modified Ross–Konno procedure.
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(P ¼ .004) (Figure 4).
Only 9 patients had immediate (n¼ 7) or late (n¼ 2)mea-
surable neo-AR on follow-up. The degree of regurgitation
was mild (n ¼ 7) or mild-moderate (n ¼ 2). This AR ratio
was stable with time (þ0.001 [0.001]/year, P ¼ .22)
(Figure 5, A). There was no difference in the AR ratio in-
crease between patients who required cardiac reoperation
and those who did not (P ¼ .23) or between those who had
preoperative stenosis and thosewho hadmixed disease or re-
gurgitation (P ¼ .27). Older patients had a trend for a more
rapid increase inAR ratiowith time (P¼ .004) (Figure 5,B).DISCUSSION
AVR in children with a small aortic annulus or complex
LVOTO has long posed a management challenge becauseThe Journal of Thoracic and Caof technical difficulties and major drawbacks of different
valve replacement options.4 The Ross procedure has
emerged as the preferable alternative in children, especially
in small infants because it was associated with low operative
mortality, superior hemodynamic characteristics, minimal
thromboembolic complications, and no anticoagulation-
related bleeding, all with consequent survival advantage
over mechanical valves.2,13,14
In patients who have undergone AVR with a mechanical
prosthesis, the risk of mortality and valve-related complica-
tions was highest in younger children receiving small pros-
theses.3,13,14 The modified Ross–Konno procedure allows
the successful treatment of complex LVOTO in that
particular high-risk subset of young patients and thus mayrdiovascular Surgery c Volume 145, Number 2 433
FIGURE 4. Trajectory of neoaortic root z score over time stratified by age
group: Older patients start with a lower neoaortic root z score immediately
after the modified Ross–Konno procedure but have a trend for a more rapid
increase in neoaortic root z score with time.
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ing AVR.13FIGURE 5. A, Trajectory of progression of AR jet width over LVOT di-
ameter ratio (AR ratio): AR ratio was stable over time. The fine solid lines
represent individual patient trajectories, and the heavy solid line is
a smoothing spline that represents the best-fit average trend over time. In-
dividual trajectories of patients with no regurgitation (AR ratio ¼ 0) over-
lap with the horizontal axis. Time zero was taken to be the date of the
modified Ross–Konno procedure. B, Trajectory of progression of AR jet
width over LVOT diameter ratio (AR ratio) over time stratified by age
groups: Older patients had a trend for a more rapid increase in AR ratio
with time. AR, Aortic regurgitation.Mortality and Reoperation
Despite surgical complexity, our study demonstrates that
the modified Ross–Konno procedure can be performed with
a low mortality risk. There were 2 operative deaths (5%) in
infants who required simultaneous mitral and aortic arch
procedures. The only late death occurred in a patient who
required late reoperation for recurrent arch obstruction. In
a recent review of patients who had undergone the Ross pro-
cedure for congenital aortic valve disease, annular enlarge-
ment using the modified Ross–Konno was not associated
with increased mortality risk; however, additional heart pa-
thology apart from LVOTO and simultaneous cardiac pro-
cedures were major factors affecting early mortality and
overall survival.15 Nonetheless, in properly selected pa-
tients, the mortality rate of those undergoing the modified
Ross–Konno procedure remains favorable compared with
young children who undergo the traditional Konno proce-
dure with a prosthetic valve.13,14,16
Although none of the patients in the current series
required late autograft reintervention, reoperations for RV-
PA conduit replacement continue to be the major downside
of the Ross procedure.17 Risk factors for conduit change that
have been identified in prior series include fresh, aortic and
smaller homografts, concomitant surgery in addition to ear-
lier surgery era.15 In the current series, later era was identi-
fied as a risk factor for conduit change and overall
reoperation. That discrepancy with prior studies can be ex-
plained by the fact that there were more neonates and small
infants who underwent the modified Ross-Konno operation
in the most recent era (25% neonates after 2001 vs 9% be-
fore 2001). Subsequently, there were more aortic homo-
grafts (47% vs 26%), smaller homografts (median 19 mm434 The Journal of Thoracic and Cardiovascular Surgvs 23 mm), and more concomitant surgery (44% vs 11%)
in patients who underwent surgery after 2001 as compared
with those who underwent surgery before 2001. Nonethe-
less, mortality risk for conduit replacement has been low,
and the advent of percutaneous pulmonary valve implanta-
tion techniques currently allowsmanagement ofRV-PAcon-
duit pathology without the need for surgery inmany patients
with late conduit dysfunction after the Ross procedure.17
Fate of the Neoaortic Annulus and Root
A key advantage of the Ross procedure in children is the
growth potential of the neoaortic annulus and root because
of the preserved autograft viability.5,6,18 It remains
debatable whether the neoaortic apparatus enlargementery c February 2013
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proportional to somatic growth or pathologic remodeling
with disproportionate and excessive dilatation.5,6,18-22
Most important, data regarding the fate of the neoaortic
apparatus in the subset of patients who underwent the
Ross–Konno procedure remain scarce. Our findings
suggest that the predominant mechanism for the increase
in neoaortic annulus and root diameters after the modified
Ross–Konno procedure was growth rather than dilatation.
Neoaortic growth was associated with preserved autograft
valve function, with few patients having mild regurgitation
that did not increase in severity with longer follow-up.
Similar to patients undergoing the Ross procedure, pa-
tients undergoing the Ross–Konno procedure may be pre-
disposed to future adverse remodeling of the neoaortic
apparatus, theoretically more so than those after the Ross
procedure alone. The incision across the aortic annulus dur-
ing the Konno aortoventriculoplasty may result in destabili-
zation of the supporting annular structure of the neoaortic
apparatus, which may lead to abnormal remodeling and di-
latation of the neoaortic apparatus with subsequent auto-
graft valve insufficiency.
The modified Ross–Konno procedure without placement
of a ventricular septal patch offers complete relief of
LVOTO comparable to that of the traditional Ross–Konno
with ventricular septal patch insertion.11,19-21 Nonetheless,
this modification might provide better preservation of the
annular structure than the traditional Ross–Konno
procedure. In a series from Philadelphia, a prior VSD
patch was identified as a risk factor for neoaortic valve
regurgitation and reintervention.22 The absence of a VSD
patch in the modified Ross–Konno procedure might have
contributed to the favorable findings of stable neoaortic
root and annulus z scores, and the relative preservation of
neoaortic valve function in our series.
Several groups of patients have been identified to be at in-
creased risk for dilatation of the neoaortic apparatus and
subsequent neoaortic valve regurgitation after the Ross pro-
cedure, including patients with preoperative AR, dilated
aortic annulus, and geometric mismatch between the origi-
nal aortic root and the pulmonary autograft.7,10,11,23 The
favorable echocardiographic findings in our series may be
explained by multiple factors. None of our subset of
patients with a small aortic annulus requiring Konno
aortoventriculoplasty naturally had a geometric mismatch
between the aortic and pulmonary valves with an aortic
annulus larger than the pulmonary valve. In addition, only
3 of our patients had pure regurgitation before surgery.
Moreover, the presence of severe aortic stenosis in the
majority of patients, with many having multilevel
LVOTO, may have been associated with preoperative
pulmonary hypertension. Pulmonary hypertension may
have led to ‘‘priming’’ of the pulmonary root through
structural changes in its wall, thus allowing it to betterThe Journal of Thoracic and Caadapt to the systemic blood pressure once it was
transitioned into the aortic position.22
Other patient characteristics, such as age at surgery and
postoperative hemodynamics, likely play a role in future
neoaortic root dilatation.24 Although our data showed that
the increase in the neoaortic annulus and root dimensions
was proportional to somatic growth, older patients in our se-
ries had a trend for a faster increase in those dimensions.We
hypothesize that the pulmonary autograft may better adapt
to the higher pressure in the aorta when it is transitioned
to the aortic position early at a younger age when smooth
muscle cells are more prone to differentiation and hyperpla-
sia, thus allowing for the required structural changes in its
wall towithstand aortic pressure. The autograft wall in older
patients with higher systemic blood pressure might with-
stand higher wall stress, which could offer a stimulus for ad-
verse remodeling and dilatation.
Only a minority of patients in our series (5%) experi-
enced neoaortic valve regurgitation more than mild, and
none required autograft reoperation during our follow-up
interval. In 7 patients in whom mild (n ¼ 5) or mild-
moderate (n ¼ 2) postoperative regurgitation developed,
neoaortic valve regurgitation remained stable and did not
worsen over time. Similar to our findings with the neoaortic
annulus and root, there was a trend for a more rapid increase
in the degree of autograft regurgitation in older patients, al-
though the increase was not statistically significant. Our ob-
servation demonstrates the association between the increase
in neoaortic root diameter and the development and pro-
gression of neoaortic valve regurgitation. Dilatation of the
annulus often leads to stretching of the neoaortic cusps
with subsequent autograft regurgitation because of the
lack of coaptation.CONCLUSIONS
The modified Ross–Konno procedure may be required in
patients with aortic stenosis associated with small aortic an-
nulus or multilevel LVOTO. The neoaortic apparatus con-
tinues to grow after the modified Ross–Konno procedure;
however, a stable annulus and root z score indicate that
this growth is proportional to somatic enlargement with
rare development of undue pathologic dilatation. The func-
tion of the aortic autograft in this subset of patients with pre-
dominantly preoperative aortic stenosis is long-lasting with
no or minimal regurgitation in the majority of patients and
no requirement for late autograft reintervention. These find-
ings support the use of the modified Ross–Konno procedure
as the aortic valve substitute of choice in children with se-
vere annular hypoplasia or complex LVOTO.References
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Dr IvanM.Rebeyka (Edmonton, Alberta, Canada).Your report
of 43 patients who underwent a Ross–Konno procedure at amedian
age of 6 years is especially noteworthy for the 0%need for autograft
reoperation at 8 years follow-up. Despite an increase in the aortic
annular diameter from14 to 21mm, therewas no significant change
in autograft annular root diameter when standardized by Z score.
I have 3 short questions. Because these results seem to be sig-
nificantly better when compared with previous reports with respect
to the need for autograft reoperation, do you think there are spe-
cific details regarding your operative technique or postoperative
management that may account for your superior results or is it sim-
ply because few of your patients had predominant AR as the initial
lesion?
Dr Alsoufi. This subset of patients by definition did not have
pure AR or aortic annulus dilatation. Both dilated aortic annulus
and pure regurgitation are established risk factors for late autograft
failure, so that alone might have contributed to the superior out-
comes in our series. We and other groups have shown that the
Ross procedure for aortic stenosis is associated with improved
freedom from autograft reoperation, so the type of patients does
play a role in the freedom from late autograft failure and
reoperation.
As for the technical aspect, our modified Ross–Konno tech-
nique without using a VSD patch might have contributed to those
superior outcomes. Several groups have shown that cutting into the
annulus and placing a VSD patch might disrupt the annular sup-
port, which might contribute to future neoaortic annulus dilatation,
regurgitation, and failure. The modification of the Ross–Konno
that we have adopted might have contributed to those superior out-
comes by preserving the annular support by not performing a large
incision into the septum and not placing a VSD patch.
One more technical consideration that we have adopted is that
the proximal suture line should be to the actual annulus rather
than to the remnants of the aortic wall, which might protect against
late dilatation.
DrRebeyka.Your article indicated that fresh as opposed to cry-
opreserved homografts were used in approximately two thirds of
the patients. Although fresh homografts are not readily available
in NorthAmerica, I was interested if youwere able to identify a dif-
ference in homograft function and longevity compared with the
cryopreserved homograft that you used in the other third of the pa-
tient group.
Dr Alsoufi. You are talking about the RV-PA homograft of
course?
Dr Rebeyka. Correct.
Dr Alsoufi. The main focus in the current series was not to as-
sess the fate of the pulmonary homograft. However, we have
looked at that in the past in larger series including all children
who have undergone the Ross procedure. In those prior series,
we found that pulmonary homografts were superior to aorticery c February 2013
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mografts, and longer follow-up was associated with more homo-
graft reoperations. One technical modification we have used
might have contributed to improved homograft longevity. We cur-
rently try to trim themuscle rim underneath the pulmonary valve to
a only a few millimeters, which has been shown to decrease the
risk of late homograft failure.
Dr Rebeyka. That is interesting because your article also
seemed to demonstrate a difference in overall conduit reoperation
rate when stratified by surgical era with worse outcomes more re-
cently, and you had a 0% 5-year operation rate in 1995 to 2000 and
a 60% reoperation rate in 2004 to 2007. Do you have any explana-
tion or insight regarding the increased overall reoperation rate in
the more recent era?
Dr Alsoufi. That’s true, and the reason for that discrepancy is
the fact that in the most recent era, we have operated on younger
and smaller patients and subsequently have used smaller homo-
grafts, more fresh and more aortic homografts, which are all risk
factors for homograft failure. Nonetheless, I believe that the larger
prior series that I’ve mentioned are more powered to accurately as-
sess factors affecting homograft survival.
Dr Ross Ungerleider (Winston Salem, NC). You have added so
much to the field over the years, and this is another addition.
Two quick questions for you. I am intrigued, especially for your
patients aged less than 3 years, with the application of your mod-
ified procedure where you do not cut into the interaventricular sep-
tum. I wonder if the Ross–Konno you are describing in this article
(ie, the modified one) is just a subset of your Ross–Konnos, be-
cause there certainly are babies with an enormous size mismatch
between a small aortic annulus and the larger pulmonary valve
where I cannot imagine that you could translocate the pulmonary
valve over to the aortic position without doing some of the typical
ventricular incision. Are these just some of your Ross–Konno pro-
cedures? Do you do some standard Ross–Konno procedures for the
babies with the big mismatch, or are you finding you can do these
even in the babies with a big mismatch?
Dr Alsoufi. This modified technique has been applied to all our
Ross–Konno cases who needed annular enlargement.
Dr Ungerleider. The other question I have relates to the
lack of disruption of the annulus. As I understand, you believeThe Journal of Thoracic and Cathis contributes to the protection of the autograft from dilata-
tion because the Z score values would make you think this is
growth. However, in adult patients who receive Ross proce-
dures there is no disruption of the annulus, and yet it is clear
that they do have autograft dilatation because their Z scores
go up. Just speculate, why would you have protection against
autograft dilatation in infants and not have protection in older
patients, and at what age do you think that lack of protection
occurs?
Dr Alsoufi. It is our hypothesis that the relative preservation of
annular support in the modified Ross–Konnomight offer an advan-
tage over the standard Ross–Konno. However, there are definitely
multiple factors that play a role in late neoaortic annular dilatation.
Even though you preserve the annulus in older patients who do not
require annular enlargement, there is probably a higher subset of
those patients who had pure AR, which is a risk factor for neoaortic
annular dilatation and autograft failure. Likewise, series of older
cohorts include more patients with a discrepancy between the
semilunar valves with the aortic valve annulus larger than the pul-
monary valve, patients with bicuspid aortic valve with regurgita-
tion, and patients with rheumatic fever. All of those risk factors
are more present in the larger population than in the Ross–Konno
population of almost a homogenous group of small patients with
pure stenosis or mixed disease. So other risk factors do interplay
in the risk of aortic annulus and root dilatation.
In addition, when you perform the Ross–Konno operation and
use the pulmonary autograft early in younger patients with signif-
icant LVOTO, most of those patients may have more pulmonary
hypertension than adult patients. So when you transfer that pulmo-
nary autograft to the aortic position at an early age, maybe it is
more primed to adapt to the systemic circulation than if you do
it in an older patient without pulmonary hypertension. Maybe
that affects the autograft remodeling. Another theory is that the
higher blood pressure the autograft is exposed to in older patients
might also contribute at least to a more significant passive early
dilatation.
All of those remain theories, and we cannot have a definitive an-
swer. Nonetheless, your comment underscores that there are sev-
eral factors that affect late dilatation of the neoaortic annulus
and root.rdiovascular Surgery c Volume 145, Number 2 437
FIGUREE1. Time-related freedom from all-cause cardiac reoperation af-
ter the modified Ross–Konno procedure stratified by surgical era (A) and
requirement of additional surgery at the time of the modified Ross–Konno
procedure (B).
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